News

Article

Pharmaceutical Technology Europe PTE

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe-01-01-2005
Volume17
Issue 1

The Use of Acrylic Resins for Improved Aqueous Enteric Coating

Author(s):

Lou Forcellini,Stephen Levine

Recent technology improvements have made acrylics the preferred system for the aqueous enteric coating of tablets

External Link - article-147555.pdf

Articles in this issue
Dessicants for Pharmaceutical Applications
US Packaging Show Displays many Pharma Machines
The Seventh Annual International Employment Survey
Issues in the Appraisal of Laser Diffraction Particle Sizing Techniques
The Use of Acrylic Resins for Improved Aqueous Enteric Coating

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Behind the Headlines, episode 7
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
June 19th 2025

BASF Opens GMP Manufacturing Facility in Michigan

Susan Haigney
The new facility offers cleanroom packaging and high-sensitivity analytical testing.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
March 12th 2025

FDA Approves First Generics of Rivaroxaban Tablets

Patrick Lavery
Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.
Drug Solutions Podcast: The Biosimilars Landscape
January 31st 2024

Drug Solutions Podcast: The Biosimilars Landscape

Feliza Mirasol
In this episode of the Drug Solutions Podcast, industry experts give an overview of the biosimilars market and discuss factors affecting not only their manufacture, but their upstake in the market as well.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
February 17th 2025

FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy

Feliza Mirasol
The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. | Image Credit: © Andreas Prott - Stock.adobe.com
February 8th 2025

Next-Generation Anti-Obesity Medicines

Cheryl Barton
European biopharma companies are looking beyond GLP-1s.